Muscle invasive bladder cancer: A single sample patient assay to predict molecular subtypes and benefit of neoadjuvant chemotherapyRoland Seiler, P. Black, Kim van Kessel et al.|European Urology Supplements|2017Cited by 1
MP34-01 MOLECULAR SUBTYPES OF MUSCLE INVASIVE BLADDER CANCER ARE RELATED TO BENEFIT FROM NEOADJUVANT CHEMOTHERAPY: DEVELOPMENT OF A SINGLE SAMPLE PATIENT ASSAYRoland Seiler, Peter C. Black, H.A.D.M. Ashab et al.|The Journal of Urology|2017Cited by 0
Plasticity in muscle-invasive bladder cancer before and after cisplatin-based neoadjuvant chemotherapyRoland Seiler, Peter C. Black, Ewan A. Gibb et al.|Urologic Oncology Seminars and Original Investigations|2017Cited by 0